021-51111890
购物车（）
sales@molnova.cn
Kinetensin
CAS No. 103131-69-7
Kinetensin ( Kinetensin (human) )
产品货号. M29815 CAS No. 103131-69-7
Kinetensin is a neurotensin-like peptide.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1066 | 有现货 |
|
| 10MG | ￥1714 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 5MG | ￥1066 | 有现货 |
|
| 10MG | ￥1714 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Kinetensin
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Kinetensin is a neurotensin-like peptide.
-
产品描述Kinetensin is a neurotensin-like peptide.(In Vitro):The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.(In Vivo):Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
-
同义词Kinetensin (human)
-
通路Others
-
靶点Other Targets
-
受体Neurotensin Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number103131-69-7
-
分子量1172.4
-
分子式C56H85N17O11
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Mogard MH, et al. The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8.
产品手册
关联产品
-
PH-46A
A potent, first-in-class, oral small-molecule agent for the treatment of inflammatory bowel diseases.
-
Exendin-3/4 (64-86)
Exendin-3/4 (64-86) is a polypeptide from patent CN 106029087 A.
-
TM-N1324
TM-N1324 is a GPR39 agonist. TM-N1324 activates human GPR39 with high efficacy and potencies of 280 nM and 9 nM in the absence and presence of Zn2+, respectively.
